BULAŞICI DERMATOLOJİK HASTALIKLARIN KONTROLÜ VE HALK SAĞLIĞI AÇISINDAN ÖNEMİ

Bulaşıcı cilt hastalıkları birinci basamak sağlık kuruluşuna sık başvuru sebeplerindendir. Bakteriyel, fungal ve paraziter hastalıklar gelişmekte olan ülkelerde daha sık görülürken, viral hastalıklar ise gelişmiş ülkelerde ön plana çıkmaktadır. Bakteriyel hastalıklardan en sık görülen piyodermidir, mantar enfeksiyonlarından ise en sık görülen dermatofitlerin etken olduğu yüzeyel mantar enfeksiyonlarıdır. Viral hastalıklardan Herpes simpleks virüs, Varisella, Molluskum kontagiozum, verru, paraziter hastalıklardan ise skabies ve pediküloz sık görülenler diğer bulaşıcı cilt hastalıklarıdır. Hastalıkların dermatolojik bulgularının tanınması ile erken tanı konulması sağlanabilir. Bulaş yolunun bilinmesi ile de hastalıkların yayılması önlenebilir. Uygun izolasyon yöntemlerinin uygulanması bulaşın azaltılmasında önem taşır.

Anahtar Kelimeler:

Bulaşıcı, cilt hastalıkları, dermatoloji, halk sağlığı

CONTROL OF INFECTIOUS SKIN DISEASES AND THEIR IMPORTANCE IN PUBLIC HEALTH

Infectious skin diseases are common among patients referring to the primary health care providers. Bacterial, fungal and parasitic diseases are more common in developing countries, while viral diseases are seen in developed countries. The most common bacterial disease is pyodermi and the most common fungal infection is superficial fungal infections caused by dermotophytes. Herpes simplex virus, Varicella, Molluscum contagiosum, verru are the most common agents among viral diseases and skabies and pediculosis are also among the common parasitic infectious diseases. Early diagnosis of diseases is possible with the recognition of dermatological findings of the diseases. Knowing the routes of transmission helps to prevent the spread of the disease. Appropriate isolation measures are important in reducing the transmission of the disease.

Keywords:

Skin diseases, transmission, dermatology, public health,

PDF

___

1. World Health Organization. (‎2005)‎. Epidemiology and management of common skin diseases in children in developing countries. Geneva : World Health Organization. http://www.who.int/iris/handle/10665/692292. Svensson A, Ofenloch RF, Bruze M, Naldi L, Cazzaniga S, Elsner P, et al. Prevalence of skin disease in a population-based sample of adults from five European countries. Br J Dermatol. 2018;178(5):1111-1118. 3. Kökçam Ġ, Saral Y. Elazığ ve Yöresinde Deri Hastalıkları. T Klin Dermatoloji 1994;4:71-74. 4. Bilen N, Seref B, Apaydin R , Başdaş F, Sal G, Dökmeci Ş, et al. Kocaeli’nde Deri Hastalıkları Konusunda Yapılan İlk Epidemiyolojik Çalışma Sonuçları. T Klin J Dermatol. 1998;8(3): 160-164.5. Bowen AC, Mahé, A, Hay RJ, Andrews RM, Steer AC, Tong SYC, et al. The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma. PLoS One. 2015;10(8): e0136789.6. George A, Rubin G. A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract. 2003;53:480–7.7. Luby SP, Agboatwalla M, Feikin DR, Painter J, Billhimer W, Altaf A, et al. Effect of handwashing on child health: a randomised controlled trial. Lancet. 2005; 366(9481): 225 -33.8. Kelly BP. Superficial fungal infections. Pediatr Rev. 2012 Apr;33(4):e22-37. 9. Fuller LC, Barton RC, Mohd Mustapa MF, Proudfoot LE, Punjabi SP, Higgins EM. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014 Sep;171(3):454-63.10. Ellis D, Watson A. Systemic antifungal agents for cutaneous fungal infections. Aust Prescr .1996;19:72-5.11. Rengasamy M, Chellam J, Ganapati S. Systemic therapy of dermatophytosis: Practical and systematic approach. Clinical Dermatology Review. 2017;1:19-23.12. Wald A, Zeh J, Selke S, Ashley R L, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med. 1995;333:770–775.13. Westhoff GL, Little SE, Caughey AB. Herpes simplex virus and pregnancy: a review of the management of antenatal and peripartum herpes infections. Obstet Gynecol Surv. 2011;66(10):629-38. 14. Holmberg SD, Stewart JA, Gerber AR, Byers RH, Lee FK, O’Malley PM et al. Prior herpes simplex virus type II infection as a risk factor for HIV infection. JAMA. 1988;259:1048-50.15. Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365. 16. Feldman S. Varicella-zoster virus pneumonitis. Chest. 1994;106:22S.17. Braue A, Ross G, Varigos G, Kelly H. Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature. Pediatr Dermatol. 2005;22:287.18. Peate I. Nursing care and treatment of the patient with human papillomavirus. Br J Nurs. 2006;15(19):1063-9.19. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356(19):1915–1927.20. Hu Y, Jiang L, Peng HL. Clinical Analysis of 134 Children with Nervous System Damage Caused by Enterovirus 71 Infection. Pediatr Infect Dis J. 2015 Jul;34(7):718-23.21. Feist H, Turowski G, Hussein K, Blöcker T, Heim A. Massive Perivillous Fibrin Deposition of an Enterovirus A-Infected Placenta Associated With Stillbirth: A Case Report. Pediatr Dev Pathol. 2018 Sep; 7:1093526618798772.22. Report of the Committee on Infectious Diseases American Academy of Pediatrics. Rubella. In: Kimberlin DW, Brady MT, Jackson MA, Long SS editors.IL. Elk Grove Village. 2015. p.688.23. Bellini WJ, Helfand RF. The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis. 2003;187 Suppl 1:S283.24. Falay T, Gurel MS. Uyuz. et Salih Gürel. T Klin J Dermatol (Özel Sayı). 2017;10(2):143-53.25. Uçmak D. Pedikuloz. T Klin J Dermatol (Özel Sayı). 2017;10(2):154-60.26. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care WHO Guidelines. [serial on the Internet] 2014]: Available from: https://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf;jsessionid=EAA714BEF182F23B8012496D99B2157B?sequence=1ttps://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf;jsessionid=EAA714BEF182F23B8012496D99B2157B?sequence=127. United States Center for Disease Control and Prevention. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Available from: https://www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines.pdf